Reuters logo
BRIEF-RedHill Biopharma receives Notice of Allowance for a new U.S. patent covering RHB-104
2017年10月23日 / 中午11点38分 / 1 个月前

BRIEF-RedHill Biopharma receives Notice of Allowance for a new U.S. patent covering RHB-104

Oct 23 (Reuters) - Redhill Biopharma Ltd

* RedHill Biopharma receives Notice of Allowance for a new U.S. patent covering RHB-104

* RedHill Biopharma - ‍enrollment in phase III study with RHB-104 for Crohn’s Disease to be completed in Nov 2017, top-line results expected in Q3/2018​

* RedHill Biopharma Ltd - ‍new patent, covering RHB-104 for relapsing-remitting multiple sclerosis (MS), is expected to be valid until 2032, once granted​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below